Pulse Biosciences: Funding, Investors & Team (Oct 2026)
Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The Company’s proprietary Nano-Pulse Stimulation technology delivers nano-second pulses of electrical energy to non-thermally clear cells while sparing adjacent non-cellular tissue. The CellFX® System is the first commercial product to harness the distinctive advantages of NPS technology to treat a variety of applications for which an optimal solution remains unfulfilled. The initial commercial use of the CellFX System is to address a range of dermatologic conditions that share high demand among patients and practitioners for improved dermatologic outcomes. Designed as a multi-application platform, the CellFX System offers customer value with a utilization-based revenue model.
Pulse Biosciences has raised $128M across 3 funding rounds on record, the most recent an undisclosed round of $13.3M announced in May 2026.
That round is above the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Pulse Biosciences Company Profile and Key Stats
Latest funding round on record: May 2026.
Pulse Biosciences Funding Rounds
Pulse Biosciences raised $50.0M in a Post-IPO Equity announced in Jul 2021.
1.8 years later, an undisclosed round of $65.0M was announced in May 2023.
3 years later, an undisclosed round of $13.3M was announced in May 2026.
Pulse Biosciences Founders and Leadership Team
Contact details for the Pulse Biosciences team: 1 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Pulse Biosciences Funding Compared to Other Health Care Startups
Pulse Biosciences' latest round of $13.3M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Pulse Biosciences in Health Care and Hayward
Companies Similar to Pulse Biosciences
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Pulse Biosciences Funding FAQs
What does Pulse Biosciences do?
Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The Company’s proprietary Nano-Pulse Stimulation technology delivers nano-second pulses of electrical energy to non-thermally clear cells while sparing adjacent non-cellular tissue. The CellFX® System is the first commercial product to harness the distinctive advantages of NPS technology to treat a variety of applications for which an optimal solution remains unfulfilled. The initial commercial use of the CellFX System is to address a range of dermatologic conditions that share high demand among patients and practitioners for improved dermatologic outcomes. Designed as a multi-application platform, the CellFX System offers customer value with a utilization-based revenue model.
How much funding has Pulse Biosciences raised?
Pulse Biosciences has raised $128M across 3 rounds on record. The most recent is an undisclosed round of $13.3M announced in May 2026.
When did Pulse Biosciences last raise funding?
Pulse Biosciences' most recent funding round on record is an undisclosed round of $13.3M, announced in May 2026.
Who founded Pulse Biosciences?
FundedIQ lists Paul Laviolette (Founder) at Pulse Biosciences.
Who is the CEO of Pulse Biosciences?
Darrin Uecker is listed as CEO at Pulse Biosciences.
Where is Pulse Biosciences headquartered?
Pulse Biosciences is based in Hayward, California, United States.
How many employees does Pulse Biosciences have?
Pulse Biosciences is in the 101-250 employee band.
How does Pulse Biosciences' funding compare to other Health Care startups?
Pulse Biosciences' latest round of $13.3M is above the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Pulse Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Pulse Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.